Tilray Inc TLRY is trading higher Monday morning after the company announced fiscal second-quarter 2022 financial results showing revenue increased year-over-year and the company reached profitability.
Tilray reported quarterly net income of $6 million, up from a loss of $89 million year-over-year. The company reported quarterly revenue of $155.15 million, up from $129.46 million, year-over-year.
Tilray attributed the revenue growth to growing cannabis revenue of $58.8 million, net beverage alcohol revenue of $13.7 million from SweetWater and wellness segment revenue of $13.8 million from Manitoba Harvest.
The company also announced a new parent company name, Tilray Brands, which it said better reflects its evolution from a Canadian LP to a global consumer packaged goods company with a portfolio of cannabis and lifestyle brands.
"Our second quarter performance reflects notable success building high-quality and highly sought-after cannabis and lifestyle CPG brands which, coupled with our scale, operational excellence and broad global distribution, enabled us to increase sales and maintain profitability despite sector-specific and macro-economic headwinds," said Irwin Simon, chairman and CEO of Tilray.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis.
TLRY Price Action: Tilray has traded as low as $6.29 and as high as $67 over a 52-week period.
The stock was up 14.9% at $7.38 at time of publication.
Photo: surfwiz17 from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.